Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04713553 |
|---|---|
| Brief Title: | A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 Against COVID-19 in Healthy Participants |
| First Submitted : | January 15, 2021 |
| First Submitted that Met QC Criteria : | January 15, 2021 |
| First Posted : | January 19, 2021 |
| Last Update Submitted that Met QC Criteria : | March 23, 2021 |
| Last Update Posted : | March 24, 2021 |